用生物疗法治疗甲基相关的淋巴扩散性疾病

Kava C Afu1, Andrew S Durkee2,3

  • 1Department of Internal Medicine, San Antonio Uniformed Services Health Education Consortium, San Antonio, USA.

Cureus
|February 3, 2025
PubMed
概括

甲托雷克萨特相关的淋巴增殖障碍是一种罕见的免疫抑制并发症,尽管初始治疗,但可能会进展. 一个独特的rituximab和brentuximab协议在不能接受化疗的患者中提供了短暂的缓解.

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K